Amyloidosis- What does it have to do with Myeloma? Anita D Souza, MD, MS Froedtert & MCW Cancer Center Milwaukee, WI

Size: px
Start display at page:

Download "Amyloidosis- What does it have to do with Myeloma? Anita D Souza, MD, MS Froedtert & MCW Cancer Center Milwaukee, WI"

Transcription

1 Amyloidosis- What does it have to do with Myeloma? Anita D Souza, MD, MS Froedtert & MCW Cancer Center Milwaukee, WI

2 Objectives Types of amyloidosis How does amyloidosis form? How is amyloidosis diagnosed? Treatment of amyloidosis Definitive Supportive care Research- new drugs on the horizon

3 What is amyloidosis? Disorder in which a protein-like material builds up in organs Not degraded Symptoms depend on organ where amyloid builds up Several types of amyloidosis, according to the protein of origin

4 Common types of systemic amyloidosis AL/Light chain- most common, ~65% ATTR Wild type (age-related) Hereditary/familial Other hereditary types Secondary (AA)

5 AL Amyloidosis Bone marrow plasma cell clone clonal free light chains misfolded light chains (AL) organ AL deposition leading to dysfunction Myeloma >10% plasma cells CRAB

6 Diagnosis- patient and caregiver experience Lousada, I et al. Adv Ther 2015

7 Suspecting amyloidosis in the diagnosis Multisystem disease Fatigue Swelling in legs, around eyes Frothy urine Dizziness with activity Big tongue Enlarged liver Periorbital bruising

8 Tissue diagnosis Diagnosis Fat pad and bone marrow Involved organ Subtype amyloid deposits Critical step before starting treatment Mass spectrometry

9 Stage of disease Prognosis Difference in free light chains NT probnp Troponin T Blood pressure Renal failure Functional status Plasma cell clone

10 Symptoms/Signs- Heart Amyloid in heart Stiff heart Heart failure Rhythm problems Symptoms, Signs Fatigue Shortness of breath Swelling Unable to lie down (from shortness of breath) Wake up gasping for breath Cough, often at night Tests Echo MRI PYP scan Blood tests (troponin, NTproBNP)

11 Symptoms/Signs- Kidney Amyloid in kidneys Nephrotic syndrome Kidney failure Symptoms, Signs Swelling in legs Puffiness around the eyes Frothy urine Tests Urine tests (24 h urine protein, urine protein/creatinine ratio Low albumin High cholesterol

12 Symptoms/Signs- Neuropathy Peripheral neuropathy Ascending numbness Muscle weakness Gait Muscle atrophy Autonomic neuropathy Dry eyes, mouth Altered sweating Dizziness Diarrhea/ constipation Bladder dysfunction Erectile dysfunction Carpal tunnel Syndrome

13 Amyloid Treatment Strategies Prevent protein misfolding Suppress amyloidogenic protein production Destabilize amyloid deposits

14 Bone marrow plasma cell clone clonal free light chains misfolded light chains (AL) organ AL deposition leading to dysfunction Effective Chemotherapy available Needs time for endogenous clearance Chemotherapy can worsen e.g. fluid retention, cardiotoxicity, neuropathy Need for clinical trials with fibrildirected therapies

15 Chemotherapy Melphalan/Dexamethasone Bortezomib (Velcade), CyBorD Lenalidomide (Revlimid) Pomalidomide (Pomalyst) Ixazomib (Ninlaro)

16 Autologous stem cell transplant Long standing responses and excellent outcomes from single centers Clinical trial showed high transplant-related mortality, 24% Jaccard, et al. NEJM 2007;357:1083

17 Real-world US/Canada data, N=1536 D Souza, A et al. J Clin Oncol 2015

18 To transplant or not to transplant? Patient selection is critical NT probnp >5000, TnT >0.06 Center experience also key Centers 4 AL transplants/year Induction treatment pre-transplant? CyBorD can convert transplant ineligible to eligible May test ability of patients to tolerate treatment BMPC >10% Gertz, et al. BMT 2013; 48:557 D Souza, et al. JCO 2015; 33:3741 Hwa, et al. AJH 2016;91:984

19 Supportive Care-heart Low salt diet Diuretics for swelling Individualized treatment (beta blockers, ACE-inhibitors, anti-arrhythmic) Blood thinners

20 Diuretics Supportive care-kidneys Albumin infusions ACE-Inhibitors Avoid nephrotoxic medications (pain medications like ibuprofen)

21 Supportive care-neuropathy Topical medication Lidoderm patch, Anesthetic cream, Capsacin Neurotropic medications Lyrica, Neurontin Cymbalta, Elavil Pain medications Anti-inflammatory (aspirin, NSAIDs) Narcotics (patch or extended release)

22 Supportive care- autonomic dysfunction Dry eyes and mouth- tear and saliva supplements Lightheadedness when standingmidodrine Diarrhea- Lomotil, loperamide, tincture opium Constipation- stool softeners Bladder dysfunction Erectile dysfunction

23 Foot care- if you can t feel your feet, you can t feel cuts or sores Foot care tips Look between and under your toes every day Wear soft, well-fitting shoes Do not walk barefoot, particularly outside Keep feet soft and well moisturized Have nails filed rather than cut A podiatrist can help

24 Carpal tunnel syndrome Ergonomic adjustment Wrist brace Local steroid injection Surgery

25 Supplements? Multivitamin supplement EGCG (green tea) Curcumin- interesting data in lab, no data in humans except case reports,?dose Known neurotoxins Cut down on alcohol (directly toxic to nerves) Stop smoking (damages blood vessels)

26 Doxycycline- old antibiotic Forloni, G, et al. FEBS Letter 2001 Ward, J, et al. Blood 2011

27 Retrospective clinical data Survival advantage for AL patients who received doxycycline prophylaxis after transplant. Kumar, S et al. ASH 2012 Case (N=16)- Control (N=22) Advanced AL: Stage 3 (N=3)/Stage 4 (N=35) Treated with chemotherapy Lowered mortality with doxycycline Wechalekar, A et al. ASH 2014, ASH 2015

28 Amyloid busters Monoclonal antibodies targeting amyloid fibrils NEOD001 (VITAL, PRONTO trials) Anti-SAP + CPHPC 11-1F4

29 NEOD001 binds AL oligomers and fibrils λ λ κ λ λ λ λ κ λ λ λ κ λ κ MonocyteMacrophage Clearance Slide courtesy: Prothena

30 Anti-CD38 antibody: Daratumumab

31 Froedtert & Medical College of Wisconsin Cancer Amyloidosis Support Groups

Amyloidosis: What to do and how to diagnose: An Update 2017

Amyloidosis: What to do and how to diagnose: An Update 2017 Amyloidosis: What to do and how to diagnose: An Update 2017 Jonathan L. Kaufman, MD Associate Professor Hematology & Oncology Winship Cancer Institute of Emory University Amyloidosis Protein Conformation/Deposition

More information

Update on Treatments for Systemic Amyloidosis

Update on Treatments for Systemic Amyloidosis Update on Treatments for Systemic Amyloidosis Laura M. Dember, M.D. Renal, Electrolyte and Hypertension Division University of Pennsylvania ANZSN Update Course Darwin, Australia September 2, 2017 Disclosure

More information

Amyloidosis and the Heart

Amyloidosis and the Heart Amyloidosis and the Heart Martha Grogan, MD October 26, 2013 2013 MFMER slide-1 Cardiac Amyloidosis Normal Heart Function How Amyloid affects the heart Symptoms Explanation of Heart Tests Treatment Options

More information

NEOD001 for amyloid light-chain (AL) amyloidosis

NEOD001 for amyloid light-chain (AL) amyloidosis NIHR Innovation Observatory Evidence Briefing: October 2017 NEOD001 for amyloid light-chain (AL) amyloidosis NIHRIO (HSRIC) ID: 10617 NICE ID: 8803 LAY SUMMARY Amyloid light-chain (AL) amyloidosis is caused

More information

M-Protien, what to do next? Ismail A Sharif MD, FRCPc Internal Medicine Day 22 nd April 2016

M-Protien, what to do next? Ismail A Sharif MD, FRCPc Internal Medicine Day 22 nd April 2016 + M-Protien, what to do next? Ismail A Sharif MD, FRCPc Internal Medicine Day 22 nd April 2016 + Disclosures Advisory Boards: AMGEN, Lundbeck, NOVARTIS + Subtypes of Plasma Cell Disorders Increased Plasma

More information

Sheena Surindran Grand Rounds 2/15/11

Sheena Surindran Grand Rounds 2/15/11 Sheena Surindran Grand Rounds 2/15/11 Affects 5 12 person per million / year 5 10% associated with myeloma Median survival without treatment is 12 40 months Most commonly affected organs are kidney, heart

More information

New approaches in amyloidosis. Philip Hawkins National Amyloidosis Centre UCL & Royal Free Hospital, London

New approaches in amyloidosis. Philip Hawkins National Amyloidosis Centre UCL & Royal Free Hospital, London New approaches in amyloidosis Philip Hawkins National Amyloidosis Centre UCL & Royal Free Hospital, London Systemic Amyloidosis Fatal protein misfolding/aggregation disease caused by accumulation of fibrillar

More information

Amyloidosis for Practicing Hematologists

Amyloidosis for Practicing Hematologists Amyloidosis for Practicing Hematologists Vishal Kukreti, MD Princess Margaret Cancer Centre October 2, 2015 Disclosures Honoraria Celgene, Janssen Ortho, Amgen, Lundbeck Objectives Case Approach subtyping,

More information

Titolo relazione. AMILOIDOSI AL L approccio terapeutico. Progetto Ematologia Romagna

Titolo relazione. AMILOIDOSI AL L approccio terapeutico. Progetto Ematologia Romagna AMILOIDOSI AL L approccio terapeutico Elena Zamagni Istituto di Ematologia «Seragnoli» Università degli Studi di Bologna Treatment of AL amyloidosis n If the serum level of the amyloidogenic protein decreases,

More information

Mayo Clinic, Rochester, Minnesota; 2 Tufts Medical Center, Boston, Massachusetts; 3

Mayo Clinic, Rochester, Minnesota; 2 Tufts Medical Center, Boston, Massachusetts; 3 NEOD001 Demonstrates Organ Biomarker Responses in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction: Final Results From a Phase 1/2 Study Morie A. Gertz, 1 Raymond L. Comenzo, 2 Heather

More information

Nerves and Neuropathy

Nerves and Neuropathy Nerves and Neuropathy Janice Wiesman MD, FAAN Associate Clinical Professor of Neurology New York University School of Medicine Adjunct Assistant Professor of Neurology Boston University School of Medicine

More information

Primary Amyloidosis. Kihyun Kim Div. of Hematology/Oncology, Dept. of Medicine, Sungkyunkwan Univ. School of Medidine Samsung Medical Center

Primary Amyloidosis. Kihyun Kim Div. of Hematology/Oncology, Dept. of Medicine, Sungkyunkwan Univ. School of Medidine Samsung Medical Center Primary Amyloidosis Kihyun Kim Div. of Hematology/Oncology, Dept. of Medicine, Sungkyunkwan Univ. School of Medidine Samsung Medical Center Systemic Amyloidosis A group of complex diseases caused by tissue

More information

COMMON SIDE EFFECTS OF MULTIPLE MYELOMA TREATMENTS TIPS FOR MANAGEMENT POWERFUL THINKING ADVANCES THE CURE SM

COMMON SIDE EFFECTS OF MULTIPLE MYELOMA TREATMENTS TIPS FOR MANAGEMENT POWERFUL THINKING ADVANCES THE CURE SM COMMON SIDE EFFECTS OF MULTIPLE MYELOMA TREATMENTS TIPS FOR MANAGEMENT POWERFUL THINKING ADVANCES THE CURE SM TIPS FOR MANAGING SOME COMMON SIDE EFFECTS OF MULTIPLE MYELOMA TREATMENT The treatment of multiple

More information

AL AMYLOIDOSIS: AN UPDATE. Simrit Parmar, MD COMY, BANGKOK

AL AMYLOIDOSIS: AN UPDATE. Simrit Parmar, MD COMY, BANGKOK AL AMYLOIDOSIS: AN UPDATE Simrit Parmar, MD COMY, BANGKOK Amyloidosis and Amyloid Fibrils Disorder of protein folding Structurally diverse precursors adopt an abnormal common fibrillar conformation New

More information

Progress in the Treatment of Cardiac Amyloidosis

Progress in the Treatment of Cardiac Amyloidosis Progress in the Treatment of Cardiac Amyloidosis Jignesh Patel MD PhD FACC FRCP Director, Cardiac Amyloid Program Medical Director, Heart Transplant Program Clinical Professor Cedars-Sinai Heart Institute,

More information

POEMS syndrome. This Infosheet explains what POEMS syndrome is, how it is diagnosed and how it is treated and managed.

POEMS syndrome. This Infosheet explains what POEMS syndrome is, how it is diagnosed and how it is treated and managed. POEMS syndrome This Infosheet explains what POEMS syndrome is, how it is diagnosed and how it is treated and managed. What is POEMS syndrome? POEMS syndrome is a rare type of plasma cell disorder that

More information

AL AMYLOIDOSIS. SAMO November 2015 Lucerne.

AL AMYLOIDOSIS. SAMO November 2015 Lucerne. AL AMYLOIDOSIS SAMO November 2015 Lucerne bernhard.gerber@eoc.ch amyloidosis diagnosis pathophysiology prognosis therapy perspectives amyloidosis diagnosis pathophysiology prognosis therapy perspectives

More information

LIVE LONGER. Chart a course that could help you. If multiple myeloma comes back:

LIVE LONGER. Chart a course that could help you. If multiple myeloma comes back: 1 If multiple myeloma comes back: Chart a course that could help you 1 LIVE LONGER -3 In two clinical studies with patients with relapsed multiple myeloma, two KYPROLIS -based combinations kept multiple

More information

The signs and symptoms of diabetic neuropathy vary, depending on the type of neuropathy and which nerves are affected.

The signs and symptoms of diabetic neuropathy vary, depending on the type of neuropathy and which nerves are affected. DIABETIC NEUROPATHY Overview Diabetic neuropathy is a type of nerve damage that can occur if you have diabetes. High blood sugar (glucose) can injure nerve fibers throughout your body, but diabetic neuropathy

More information

Management of the complications of myeloma and side-effects of treatment Christine Morris Clinical Nurse Specialist in Myeloma Royal Derby Hospital

Management of the complications of myeloma and side-effects of treatment Christine Morris Clinical Nurse Specialist in Myeloma Royal Derby Hospital Management of the complications of myeloma and side-effects of treatment Christine Morris Clinical Nurse Specialist in Myeloma Royal Derby Hospital Common problems in myeloma Myeloma-related complications/symptoms

More information

The recommended protocol is for all patients suffering from diabetes to have yearly foot checks. This was checking the foot pulses and doing

The recommended protocol is for all patients suffering from diabetes to have yearly foot checks. This was checking the foot pulses and doing Foot disease is a common long-term complication of diabetes. There are different types of foot disease caused by diabetes, but they all stem from a similar process. Raised blood sugar for a prolonged amount

More information

Myeloma care and proteasome inhibitors. Brendan M. Weiss, MD Abramson Cancer Center University of Pennsylvania

Myeloma care and proteasome inhibitors. Brendan M. Weiss, MD Abramson Cancer Center University of Pennsylvania Myeloma care and proteasome inhibitors Brendan M. Weiss, MD Abramson Cancer Center University of Pennsylvania Why care about CV toxicities in MM? Median age 72 years About 2/3 have CV disease at baseline

More information

Amiloidosi AL: clinica, esami diagnostici e prognosi

Amiloidosi AL: clinica, esami diagnostici e prognosi Titolo relazione Amiloidosi AL: clinica, esami diagnostici e prognosi Giovanni Palladini Amyloidosis: protein misfolding disease! Titolo relazione Clinical presentation of the most common forms of Titolo

More information

Diet and nutrition. AL amyloidosis. Living well with. Infosheet Series. AL amyloidosis. Infoline:

Diet and nutrition. AL amyloidosis. Living well with. Infosheet Series. AL amyloidosis. Infoline: Diet and nutrition This Infosheet explains what a well-balanced diet is, what can make it difficult to maintain when you are an AL amyloidosis patient, when a special diet might be necessary and tips for

More information

Fuel your determination to live longer with KYPROLIS. Look inside to learn more.

Fuel your determination to live longer with KYPROLIS. Look inside to learn more. F O R R E L A P S E D MULT IP L E M Y E L OM A APPROVED USES KYPROLIS is a prescription medication used to treat patients with relapsed or refractory multiple myeloma who have received one to three previous

More information

Docetaxel (Taxotere )

Docetaxel (Taxotere ) Page 1 of 5 Docetaxel (Taxotere ) About This Drug Docetaxel is used to treat cancer. It is given in the vein (IV). Possible Side Effects Bone marrow depression. This is a decrease in the number of white

More information

Education Brochure. Hereditary ATTR amyloidosis A closer look at an inherited condition

Education Brochure. Hereditary ATTR amyloidosis A closer look at an inherited condition Education Brochure Hereditary ATTR amyloidosis A closer look at an inherited condition What is hereditary ATTR (hattr) amyloidosis? hattr amyloidosis is caused by a gene change (mutation) that affects

More information

Amyloidosis Information. A General Overview for Patients

Amyloidosis Information. A General Overview for Patients Amyloidosis Information A General Overview for Patients www.amyloidosis.org Amyloidosis was first discovered 150 years ago by the well know German pathologist, Dr. Rudolf Virchow. Although the disease

More information

Amyloidosis and the Heart

Amyloidosis and the Heart Patient Information Amyloidosis and the Heart What are the symptoms of heart failure? Introduction In some patients with amyloidosis there is a build-up of amyloid deposits in the heart muscle. This may

More information

Management of complications and side-effects of myeloma. Jackie Quinn Myeloma CNS Belfast Trust

Management of complications and side-effects of myeloma. Jackie Quinn Myeloma CNS Belfast Trust Management of complications and side-effects of myeloma Jackie Quinn Myeloma CNS Belfast Trust Common problems in myeloma Myeloma-related complications/symptoms Treatment-related side-effects Myeloma bone

More information

A Problem with Cardiac Amyloidosis. Defining Amyloidosis. Typical Amyloid Heart. Definition of a double-blind study:

A Problem with Cardiac Amyloidosis. Defining Amyloidosis. Typical Amyloid Heart. Definition of a double-blind study: A disease caused by the deposition of a proteinaceous material, derived from the misfolded breakdown products of a normal or abnormal protein. Typical Amyloid Heart Defining Amyloidosis TYPEOF AMYLOID

More information

DOB Age Sex Weight Height Right Handed Left handed

DOB Age Sex Weight Height Right Handed Left handed Lee Ann Brown, D.O. Date: Patient Name DOB Age Sex Weight Height Right Handed Left handed Marital Status S M D W Is your problem related to: Car /Bike accident Yes/No Date Slip or Fall accident Yes/No

More information

Congestive Heart Failure

Congestive Heart Failure Congestive Heart Failure GENERAL INFORMATION: What is congestive heart failure? Congestive heart failure is a life-threatening disease that occurs when your heart becomes too weak to pump blood properly.

More information

Amyloidosis. Philip Hawkins National Amyloidosis Centre UCL & Royal Free Hospital, London

Amyloidosis. Philip Hawkins National Amyloidosis Centre UCL & Royal Free Hospital, London Amyloidosis Philip Hawkins National Amyloidosis Centre UCL & Royal Free Hospital, London Amyloid Abnormal extracellular fibrillar protein deposit in tissues Pathognomonic red-green birefringence after

More information

Methotrexate. About This Drug. Possible Side Effects. Warnings and Precautions

Methotrexate. About This Drug. Possible Side Effects. Warnings and Precautions Methotrexate About This Drug Methotrexate is used to treat cancer. This drug is given in the vein (IV). Possible Side Effects Soreness of the mouth and throat. You may have red areas, white patches, or

More information

Bridges Family Wellness PC. New Patient Intake. Bridges Family Wellness Intake Form SE Lake Rd, Suite 102 Milwaukie, OR

Bridges Family Wellness PC. New Patient Intake. Bridges Family Wellness Intake Form SE Lake Rd, Suite 102 Milwaukie, OR New Patient Intake Bridges Family Wellness Intake Form Full Name: * What is your birthdate? MM/DD/YYYY * What is your gender identity? * Home address: * Cell Phone * Other Phone number(s): Emergency Contact

More information

Amarillo Surgical Group Doctor: Date:

Amarillo Surgical Group Doctor: Date: Office Visit Information (General Surgery) Amarillo Surgical Group Doctor: Date: Patient s Information Name: Last First Middle Social Security #: Date of Birth: Age Gender: [ Male / Female ] Marital Status:

More information

Center for Amyloidosis and Acute Phase Proteins, University College London Medical School, UK

Center for Amyloidosis and Acute Phase Proteins, University College London Medical School, UK Use of plasma cell immunophenotype as prognostic markers in patients with systemic AL amyloidosis Sajitha Sachchithanantham 1*, Anna Baginska 1*, Dorota Rowczenio 1, Shameem A Mahmood 1, Rabya Sayed 1,

More information

Clinical trials evaluating potential therapies for light chain (AL) amyloidosis

Clinical trials evaluating potential therapies for light chain (AL) amyloidosis Expert Opinion on Orphan Drugs ISSN: (Print) 2167-8707 (Online) Journal homepage: http://www.tandfonline.com/loi/ieod20 Clinical trials evaluating potential therapies for light chain (AL) amyloidosis Eli

More information

Systemic amyloidosis with cardiac involvement

Systemic amyloidosis with cardiac involvement 034 Cardiology Systemic amyloidosis with cardiac involvement Amyloidosis is a term used to describe a group of disorders consisting of abnormalities in and the accumulation of amyloid protein. This protein

More information

: A Study Examining the Prevalence of Transthyretin Mutations in Subjects Suspected of Having Cardiac Amyloidosis

: A Study Examining the Prevalence of Transthyretin Mutations in Subjects Suspected of Having Cardiac Amyloidosis : A Study Examining the Prevalence of Transthyretin Mutations in Subjects Suspected of Having Cardiac Amyloidosis 02 November 2015 1 Background and Rationale Cardiac amyloidosis is caused by extracellular

More information

Diabetes. HED\ED:NS-BL 037-3rd

Diabetes. HED\ED:NS-BL 037-3rd Diabetes HED\ED:NS-BL 037-3rd Diabetes Diabetes mellitus is an epidemic disease and based on a recent study published on 2011, the estimated number of affected people is 366 million worldwide and the number

More information

Management of Multiple Myeloma: The Changing Paradigm

Management of Multiple Myeloma: The Changing Paradigm Management of Multiple Myeloma: The Changing Paradigm Frontline Therapy for Newly Diagnosed Patients Saad Usmani, MD FACP Levine Cancer Institute Introduction: Case Presentation 64-year-old woman with

More information

Preventing Bleeding When You Have a Low Platelet Count

Preventing Bleeding When You Have a Low Platelet Count PATIENT EDUCATION patienteducation.osumc.edu Preventing Bleeding When You Have a Low Platelet Count What is a low platelet count? A platelet count measures the number of platelets you have in your blood.

More information

EDUCATION. Peripheral Artery Disease

EDUCATION. Peripheral Artery Disease EDUCATION Peripheral Artery Disease Peripheral Artery Disease You may have circulation problems that have to do with your blood vessels. You may feel aches, pains, cramps, numbness or muscle fatigue when

More information

Ibrutinib (Imbruvica )

Ibrutinib (Imbruvica ) Ibrutinib (Imbruvica ) ( eye BROO ti nib ) How drug is given: by mouth Purpose: to stop the growth of cancer cells in lymphoma and other cancers How to take the drug Take each dose at the same time every

More information

Myeloma Haematology and Transplant Unit

Myeloma Haematology and Transplant Unit BCD Myeloma Haematology and Transplant Unit BCD This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the

More information

How is this regimen given? Are there other medications I will receive with this regimen? What side effects can occur with this regimen?

How is this regimen given? Are there other medications I will receive with this regimen? What side effects can occur with this regimen? Weekly Paclitaxel Weekly paclitaxel (Taxol ) is a chemotherapy regimen or treatment plan that your doctor prescribed for the treatment of your cancer. How is this regimen given? Paclitaxel (Taxol ) is

More information

Nivolumab. Other Names: Opdivo. About this Drug. Possible Side Effects (More Common) Warnings and Precautions

Nivolumab. Other Names: Opdivo. About this Drug. Possible Side Effects (More Common) Warnings and Precautions Nivolumab Other Names: Opdivo About this Drug Nivolumab is used to treat cancer. It is given in the vein (IV). Possible Side Effects (More Common) Bone marrow depression. This is a decrease in the number

More information

Final Analysis of the Phase 1a/b Study of Fibril-Reactive Monoclonal Antibody 11-1F4 (CAEL-101) in Patients with AL Amyloidosis

Final Analysis of the Phase 1a/b Study of Fibril-Reactive Monoclonal Antibody 11-1F4 (CAEL-101) in Patients with AL Amyloidosis Final Analysis of the Phase 1a/b Study of Fibril-Reactive Monoclonal Antibody 11-1F4 (CAEL-101) in Patients with AL Amyloidosis Camille V. Edwards 1, Divaya Bhutani 2, Markus Mapara 2, Jai Radhakrishnan

More information

Lenvatinib (Lenvima ) ( len-va-ti-nib )

Lenvatinib (Lenvima ) ( len-va-ti-nib ) Lenvatinib (Lenvima ) ( len-va-ti-nib ) How drug is given: By mouth Purpose: To treat thyroid cancer or other cancers How to take this drug This medicine can be taken with or without food. Take each dose

More information

Management of Multiple Myeloma: The Changing Paradigm

Management of Multiple Myeloma: The Changing Paradigm Management of Multiple Myeloma: The Changing Paradigm Supportive Care for Patients With Multiple Myeloma Brittany Wolfe, PA-C University of Chicago Multiple Myeloma Program www.cancer.gov Effects of Myeloma

More information

LIGHT CHAIN DISEASE B. DHANALAKSHMI 1 & V. HEMAVATHY 2

LIGHT CHAIN DISEASE B. DHANALAKSHMI 1 & V. HEMAVATHY 2 TJPRC: International Journal of Nursing and Patient Safety & Care (TJPRC: IJNPSC) Vol. 1, Issue 1, Dec 2016, 21-24 TJPRC Pvt. Ltd. LIGHT CHAIN DISEASE B. DHANALAKSHMI 1 & V. HEMAVATHY 2 1 Associate Professor,

More information

Diagnosis & Management. Michael Rosenzweig, MD How The Experts Treat Hematologic Malignancies March 16, 2017

Diagnosis & Management. Michael Rosenzweig, MD How The Experts Treat Hematologic Malignancies March 16, 2017 Light Chain (AL) Amyloidosis i Diagnosis & Management Michael Rosenzweig, MD How The Experts Treat Hematologic Malignancies March 16, 2017 Disclosures Speakers Bureau: Celgene Bristol-Myers Squibb Amyloidosis:

More information

Jo Abraham MD Division of Nephrology University of Utah

Jo Abraham MD Division of Nephrology University of Utah Jo Abraham MD Division of Nephrology University of Utah 68 year old male presented 3 weeks ago with a 3 month history of increasing fatigue He reported a 1 week history of increasing dyspnea with a productive

More information

Management of Multiple Myeloma: The Changing Paradigm

Management of Multiple Myeloma: The Changing Paradigm Management of Multiple Myeloma: The Changing Paradigm High-Dose Chemotherapy and Stem Cell Transplantation Todd Zimmerman, MD University of Chicago Medical Center Case Presentation R.M. is a 64 year old

More information

A Guide for People With Diabetes. Take Care of Your Feet for a

A Guide for People With Diabetes. Take Care of Your Feet for a A Guide for People With Diabetes Take Care of Your Feet for a You can take care of your feet! Do you want to avoid serious foot problems that can lead to a toe, foot, or leg amputation? Take Care of Your

More information

Light Chain (AL) Amyloidosis Diagnosis & Management. Michael Rosenzweig, MD How The Experts Treat Hematologic Malignancies March 21, 2019

Light Chain (AL) Amyloidosis Diagnosis & Management. Michael Rosenzweig, MD How The Experts Treat Hematologic Malignancies March 21, 2019 Light Chain (AL) Amyloidosis Diagnosis & Management Michael Rosenzweig, MD How The Experts Treat Hematologic Malignancies March 21, 2019 Disclosures I am on the speakers bureau for Celgene and Akcea pharmaceuticals

More information

Our Vision NADA BoD Strategic Planning Session -

Our Vision NADA BoD Strategic Planning Session - Who we are NADA is a not-for-profit members-led organization established in 1995 as a result of the rising rates of diabetes among First Nations, Inuit and Métis Peoples in Canada Our Vision - 2016 NADA

More information

6/6/2017. Uncommon Etiologies of Heart Failure: Cardiac Amyloidosis. Objectives. Case Presentation

6/6/2017. Uncommon Etiologies of Heart Failure: Cardiac Amyloidosis. Objectives. Case Presentation Uncommon Etiologies of Heart Failure: Cardiac Amyloidosis Maria Fe White, MSN, FNP/ACNP-BC, FHFSA, CHFN Lead Nurse Practitioner Advance Heart Programs Comprehensive Transplant Center Objectives Describe

More information

For the Patient: UMYLDREL

For the Patient: UMYLDREL For the Patient: UMYLDREL Other Names: Treatment of Multiple Myeloma Using Lenalidomide (REVLIMID ) and Dexamethasone MY = MYeloma (tumour group) L = Lenalidomide D = Dexamethasone REL = RELapse Uses:

More information

Update in Nuclear Imaging of Amyloidosis and Sarcoidosis

Update in Nuclear Imaging of Amyloidosis and Sarcoidosis Update in Nuclear Imaging of Amyloidosis and Sarcoidosis Balaji Tamarappoo MD, PhD, Cedars-Sinai Heart Institute and Biomedical Imaging Research Institute Cedars-Sinai Medical Center Los Angeles, CA, USA.

More information

treatment Update: Multiple Myeloma CancerCare Booklet Series

treatment Update: Multiple Myeloma CancerCare Booklet Series treatment Update: Multiple Myeloma CancerCare Connect Booklet Series www.cancercare.org The CancerCare Connect Booklet Series offers up-to-date, easy-to-read information on the latest treatments, managing

More information

Type 2 Diabetes. Care for your body today for a healthier tomorrow

Type 2 Diabetes. Care for your body today for a healthier tomorrow Type 2 Diabetes Care for your body today for a healthier tomorrow Understanding diabetes You may already know that having diabetes means you have too much sugar in your blood. Why do you have high blood

More information

Hereditary ATTR amyloidosis Talking to your healthcare professional about a hereditary condition

Hereditary ATTR amyloidosis Talking to your healthcare professional about a hereditary condition Healthcare Professional Discussion Guide Hereditary ATTR amyloidosis Talking to your healthcare professional about a hereditary condition This guide will give you some tips and strategies to help you start

More information

Management of Multiple Myeloma

Management of Multiple Myeloma Management of Multiple Myeloma Damian J. Green, MD Fred Hutchinson Cancer Research Center/ Seattle Cancer Care Alliance New Treatment Options Have Improved OS in MM Kumar SK, et al. Blood. 2008;111:2516-2520.

More information

New Patient History. Name: DOB: Sex: Date: If yes, give the name of the physician who did your evaluation or ordered your tests:

New Patient History. Name: DOB: Sex: Date: If yes, give the name of the physician who did your evaluation or ordered your tests: New Patient History Name: DOB: Sex: Date: Chief Complaint: 1. Give a brief description of the problem you are seeking treatment for today: 2. Have you been evaluated for this problem or had any tests for

More information

Sorafenib (so-ra-fe-nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth.

Sorafenib (so-ra-fe-nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth. For the Patient: Other names: Sorafenib NEXAVAR Sorafenib (so-ra-fe-nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth. A blood test may be taken before each

More information

Using the symbols below, please draw in the location of your symptoms on the diagrams. X = Pain 0 = Numbness / = Aching * = Pins & Needles

Using the symbols below, please draw in the location of your symptoms on the diagrams. X = Pain 0 = Numbness / = Aching * = Pins & Needles Date: DOB: Age: Gender: Right handed: Left handed: Who referred you? Is your problem related to : Job injury Date: Car accident Date: Date: Briefly describe your main problem/complaint. Also, describe

More information

Capecitabine and Lapatinib

Capecitabine and Lapatinib PATIENT EDUCATION patienteducation.osumc.edu What is Capecitabine (ka-pe-site-a-been) and how does it work? Capecitabine is an oral chemotherapy drug known as an antimetabolite. Another name for this drug

More information

Myeloma Support Group: Now and the Horizon. Brian McClune, DO

Myeloma Support Group: Now and the Horizon. Brian McClune, DO Myeloma Support Group: Now and the Horizon Brian McClune, DO Disclosures Consultant to Celgene Objectives Transplant for myeloma- is there any thing new? High risk disease University protocols New therapies?

More information

Diabetes - Foot Care

Diabetes - Foot Care Diabetes - Foot Care Introduction People with diabetes are more likely than others to have problems with their feet. These problems can lead to dangerous infections of the foot. Recognizing and treating

More information

Headache Follow-up Visit Form

Headache Follow-up Visit Form !1 Headache Follow-up Visit Form We will be unable to see you unless this form is completely filled out. We appreciate your thoroughness. Name DOB Age Today s Date Referring doctor: Primary doctor: Neurologist:

More information

Summary of plenary sessions on October 31, 2015

Summary of plenary sessions on October 31, 2015 4 th ATTR/Familial Amyloidosis Support Meeting October 31 to November 1, 2015 Hilton Chicago O Hare Airport hotel Summary of plenary sessions on October 31, 2015 1 Contents Welcome... 3 Why are we here?

More information

For the Patient: Mitoxantrone Other names:

For the Patient: Mitoxantrone Other names: For the Patient: Mitoxantrone Other names: Mitoxantrone (mite-oh-zan-trone) is a drug that is used to treat many types of cancer. It is a blue liquid that is injected into a vein. Tell your doctor if you

More information

Laboratory Examination

Laboratory Examination Todd Zimmerman, M.D. 64 year old African American male presents to establish care with PCG. Meds: Norvasc 5 mg daily PMHx: HTN x 20 years, poorly controlled SHx: No tobacco, illicit; rare EtOH ROS: Negative

More information

Diagnostic approach to cardiac amyloidosis: A case report

Diagnostic approach to cardiac amyloidosis: A case report Diagnostic approach to cardiac amyloidosis: A case report Georgia Vogiatzi, MD, MSc, PhD 1 st Cardiology Department, Hippokration Hospital, Athens Medical School Disclosures I have no relevant relationships

More information

Diabetes is a serious disease that can develop from lack of insulin production in the body or due to

Diabetes is a serious disease that can develop from lack of insulin production in the body or due to Page 1 The Diabetic Foot Definition Diabetes is a serious disease that can develop from lack of insulin production in the body or due to the inability of the body's insulin to perform its normal everyday

More information

NEW SPINE PATIENT QUESTIONNAIRE

NEW SPINE PATIENT QUESTIONNAIRE NEW SPINE PATIENT QUESTIONNAIRE Patient Name (please print) Date Age Birthdate Gender: Male Female Primary Care Doctor Phone# Referring Doctor Phone# We routinely send a copy of all clinic notes to your

More information

AL amyloidosis An introduction An Introduction

AL amyloidosis An introduction An Introduction AL amyloidosis An introduction An Introduction Essentials This Introduction has been made possible thanks to the generosity of Myeloma UK supporters. To find out how you can support our vital work call

More information

How can DIABETES affect my FEET? Emma Howard Specialist Podiatrist and Team Leader, Oxford Health NHS Foundation Trust

How can DIABETES affect my FEET? Emma Howard Specialist Podiatrist and Team Leader, Oxford Health NHS Foundation Trust How can DIABETES affect my FEET? By: Emma Howard Specialist Podiatrist and Team Leader, Oxford Health NHS Foundation Trust HOW CAN DIABETES AFFECT MY FEET? What is neuropathy? This leaflet explains how

More information

VIDE. Vincristine given via intravenous (IV) infusion over 10 minutes Etoposide & doxorubicin given together via IV infusion over 4 hours

VIDE. Vincristine given via intravenous (IV) infusion over 10 minutes Etoposide & doxorubicin given together via IV infusion over 4 hours VIDE VIDE This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others it may

More information

Review Article Autologous Stem Cell Transplant for AL Amyloidosis

Review Article Autologous Stem Cell Transplant for AL Amyloidosis Bone Marrow Research Volume 2012, Article ID 238961, 5 pages doi:10.1155/2012/238961 Review Article Autologous Stem Cell Transplant for AL Amyloidosis Vivek Roy Division of Hematology/Oncology, Mayo Clinic,

More information

Dabrafenib (Tafinlar )

Dabrafenib (Tafinlar ) Dabrafenib (Tafinlar ) ( da-braf-e-nib ) How drug is given: By mouth Purpose: To stop the growth of cancer cells in melanoma and other cancers. How to take this drug Take this medication on an empty stomach

More information

For the Patient: Lenvatinib Other names: LENVIMA

For the Patient: Lenvatinib Other names: LENVIMA For the Patient: Lenvatinib Other names: LENVIMA Lenvatinib (len va' ti nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth. Tell your doctor if you have ever

More information

VDC IE. Your treatment You will have 14 cycles of VDC IE given every 2 to 3 weeks.

VDC IE. Your treatment You will have 14 cycles of VDC IE given every 2 to 3 weeks. VDC IE VDC IE This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others

More information

Peripheral neuropathy

Peripheral neuropathy Peripheral neuropathy This Infosheet explains what the peripheral nervous system is, what peripheral neuropathy is, what causes it in AL amyloidosis patients, its symptoms and treatments and tips for self-management.

More information

Medical Policy Title: HDC Progenitor Cell ARBenefits Approval: 02/08/2012

Medical Policy Title: HDC Progenitor Cell ARBenefits Approval: 02/08/2012 Medical Policy Title: HDC Progenitor Cell ARBenefits Approval: 02/08/2012 Support AL Amyloidosis (Light Chain Amyloidosis) Effective Date: 01/01/2013 Document: ARB0413:01 Revision Date: 10/24/2012 Code(s):

More information

ACTION CHIROPRACTIC & SPORT THERAPY 7744 Elbow Drive SW Calgary, AB T2V 1K2 Phone: Fax: Full Name: Address:

ACTION CHIROPRACTIC & SPORT THERAPY 7744 Elbow Drive SW Calgary, AB T2V 1K2 Phone: Fax: Full Name: Address: ACTION CHIROPRACTIC & SPORT THERAPY 7744 Elbow Drive SW Calgary, AB T2V 1K2 Phone: 403.243.8114 Fax: 403.212.0880 Full Name: Address: City: Province: Postal Code: Date of Birth (MM/DD/YYYY): Home Phone:

More information

For the Patient: Sunitinib Other names: SUTENT

For the Patient: Sunitinib Other names: SUTENT For the Patient: Sunitinib Other names: SUTENT Sunitinib (soo-ni-ti-nib) is a drug that is used to treat different types of cancer. It is a capsule that you take by mouth. A blood test and blood pressure

More information

For the Patient: Doxorubicin pegylated liposomal Other names: CAELYX, DOXIL, PLD

For the Patient: Doxorubicin pegylated liposomal Other names: CAELYX, DOXIL, PLD For the Patient: Doxorubicin pegylated liposomal Other names: CAELYX, DOXIL, PLD Pegylated liposomal doxorubicin (dox-oh-roo-biss-in) is a drug that is used to treat many types of cancers. Pegylated liposomal

More information

Amiloidosis AL Tratamiento. Joan Bladé Asturias, 6 de Noviembre de 2012

Amiloidosis AL Tratamiento. Joan Bladé Asturias, 6 de Noviembre de 2012 Amiloidosis AL Tratamiento Joan Bladé Asturias, 6 de Noviembre de 2012 AL Concept Incidence: 5-12 persons per million per year Clonal bone marrow plasma cells Amyloid precursor: variable region of LC (80%

More information

Update on systemic amyloidosis Dr Ashutosh Wechalekar

Update on systemic amyloidosis Dr Ashutosh Wechalekar Update on systemic amyloidosis Dr Ashutosh Wechalekar Reader in Haematology and Medicine University College London UK Amyloidosis SAP GAG s IL- 6 mediated release Serum Amyloid A Oligomers Mis-folding

More information

Sorafenib (Nexavar ) ( sor-af-e-nib )

Sorafenib (Nexavar ) ( sor-af-e-nib ) Sorafenib (Nexavar ) ( sor-af-e-nib ) How the drug is given: by mouth Purpose: To stop the growth of cancer cells in kidney cancer, liver cancer, and other cancers How to take the drug by mouth Take on

More information

5 Fluorouracil. Other Names: Adrucil. About This Drug. Possible Side Effects. Fluorouracil is used to treat cancer.it is given in the vein (IV).

5 Fluorouracil. Other Names: Adrucil. About This Drug. Possible Side Effects. Fluorouracil is used to treat cancer.it is given in the vein (IV). 5 Fluorouracil Other Names: Adrucil About This Drug Fluorouracil is used to treat cancer.it is given in the vein (IV). Possible Side Effects Hair loss. Hair loss is often temporary, although with certain

More information

Managing Fluid, Diet and Medications

Managing Fluid, Diet and Medications Managing Fluid, Diet and Medications This lesson covers: Fluid and body weight Managing your diet Understanding your medications It is important that you feel comfortable with the information and procedures

More information

For the Patient: Eribulin Other names: HALAVEN

For the Patient: Eribulin Other names: HALAVEN For the Patient: Eribulin Other names: HALAVEN Eribulin (er'' i bue' lin) is a drug that is used to treat some types of cancer. It is a clear liquid that is injected into a vein. Tell your doctor if you

More information

Prothena Corporation plc Overview

Prothena Corporation plc Overview November 11, 2014 Prothena Corporation plc Overview 2014 Credit Suisse HC Conference The Arizona Biltmore Phoenix, AZ Forward-Looking Statements This presentation contains forward-looking statements. These

More information

What is Capecitabine (ka-pe-site-a-been) and how does it work?

What is Capecitabine (ka-pe-site-a-been) and how does it work? PATIENT EDUCATION patienteducation.osumc.edu What is (ka-pe-site-a-been) and how does it work? is an oral chemotherapy drug known as an antimetabolite. Another name for this drug is Xeloda. can be given

More information

Atrial Fibrillation. Damage to your heart caused by a heart attack or rheumatic heart disease

Atrial Fibrillation. Damage to your heart caused by a heart attack or rheumatic heart disease Atrial Fibrillation GENERAL INFORMATION: What is atrial fibrillation? Atrial fibrillation is a condition that causes the atria (top chambers of the heart) to shake or quiver. Normally, there is 1 contraction

More information